ROS and esterase dual-responsive nano-preparation, and preparation method and application thereof
By designing ROS and esterase dual-responsive nanoformulations, itaconic acid drugs are released at the site of liver injury using nanoparticles with a hydrophobic core and a hydrophilic shell. This solves the problems of narrow time window and large side effects of existing treatments, and achieves highly efficient targeted therapy for drug-induced liver injury.
CN119896748BActive Publication Date: 2026-06-19OCEAN UNIV OF CHINA
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- OCEAN UNIV OF CHINA
- Filing Date
- 2025-01-09
- Publication Date
- 2026-06-19
Smart Images

Figure CN119896748B_ABST
Abstract
This invention relates to a ROS- and esterase-responsive nano-formulation, its preparation method, and its application, belonging to the field of nano-formulation technology. The nano-formulation of this invention uses itaconic acid as a hyperbranched polymer backbone after modification. Upon reaching the inflammatory site, the hyperbranched polymer first disintegrates in response to ROS stimulation, and then releases the active pharmaceutical ingredient of itaconic acid under the further action of esterases. This significantly improves the cell membrane permeability and bioavailability of exogenous itaconic acid. Secondly, compared with nano-formulations encapsulating therapeutic agents, the nano-formulation of this invention has an almost pure drug core, thus exhibiting higher drug loading capacity and lower toxicity. Furthermore, by using the therapeutic agent as the nanocarrier backbone, the nano-formulation of this invention effectively avoids premature leakage of the therapeutic agent and the problem of clearing foreign substances after the parent drug is released.
Need to check novelty before this filing date? Find Prior Art